Gastric adenocarcinoma (GC) is a leading cause of cancer-related deaths worldwide. The transcription factor gene
Friend Leukemia Integration 1
(
FLI1
) is methylated and downregulated in human GC tissues. Using human GC samples, we determined which cells downregulate
FLI1
, when
FLI1
downregulation occurs, if
FLI1
downregulation correlates with clinical-pathologic characteristics, and whether
FLI1
plays a role in invasion and/or proliferation of cultured cells. We analyzed stomach tissues from 98 patients [8 normal mucosa, 8 intestinal metaplasia (IM), 7 dysplasia, 91 GC] by immunohistochemistry for FLI1. Epithelial cells from normal, IM, and low-grade dysplasia (LGD) showed strong nuclear FLI1 staining. GC epithelial cells showed significantly less nuclear FLI1 staining as compared to normal epithelium, IM and LGD (P=1.2×10
-5
, P=1.4×10
-6
and P=0.006, respectively).
FLI1
expression did not correlate with tumor stage or differentiation, but was associated with patient survival, depending on tumor differentiation. We tested the functional role of FLI1 by assaying proliferation and invasion in cultured GC cells. Lentiviral-transduced
FLI1
overexpression in GC AGS cells inhibited invasion by 73.5% (P = 0.001) and proliferation by 31.5% (P = 0.002), as compared to controls. Our results support a combined role for FLI1 as a suppressor of invasiveness and proliferation in gastric adenocarcinoma, specifically in the transition from pre-cancer lesions and dysplasia to invasive adenocarcinoma, and suggest that FLI1 may be a prognostic biomarker of survival in gastric cancers.